ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Examine the Safety and Tolerability of Single Ascending Doses of REGN2477

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02870400
Recruitment Status : Completed
First Posted : August 17, 2016
Last Update Posted : February 20, 2017
Sponsor:
Information provided by (Responsible Party):
Regeneron Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 12, 2017
  Actual Study Completion Date : January 12, 2017